» Articles » PMID: 22428026

Generation of a Convalescent Model of Virulent Francisella Tularensis Infection for Assessment of Host Requirements for Survival of Tularemia

Overview
Journal PLoS One
Date 2012 Mar 20
PMID 22428026
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Francisella tularensis is a facultative intracellular bacterium and the causative agent of tularemia. Development of novel vaccines and therapeutics for tularemia has been hampered by the lack of understanding of which immune components are required to survive infection. Defining these requirements for protection against virulent F. tularensis, such as strain SchuS4, has been difficult since experimentally infected animals typically die within 5 days after exposure to as few as 10 bacteria. Such a short mean time to death typically precludes development, and therefore assessment, of immune responses directed against virulent F. tularensis. To enable identification of the components of the immune system that are required for survival of virulent F. tularensis, we developed a convalescent model of tularemia in C57Bl/6 mice using low dose antibiotic therapy in which the host immune response is ultimately responsible for clearance of the bacterium. Using this model we demonstrate αβTCR(+) cells, γδTCR(+) cells, and B cells are necessary to survive primary SchuS4 infection. Analysis of mice deficient in specific soluble mediators shows that IL-12p40 and IL-12p35 are essential for survival of SchuS4 infection. We also show that IFN-γ is required for survival of SchuS4 infection since mice lacking IFN-γR succumb to disease during the course of antibiotic therapy. Finally, we found that both CD4(+) and CD8(+) cells are the primary producers of IFN-γand that γδTCR(+) cells and NK cells make a minimal contribution toward production of this cytokine throughout infection. Together these data provide a novel model that identifies key cells and cytokines required for survival or exacerbation of infection with virulent F. tularensis and provides evidence that this model will be a useful tool for better understanding the dynamics of tularemia infection.

Citing Articles

Non-vaccinal prophylaxis of tularemia.

Maurin M, Hennebique A, Brunet C, Ponderand L, Pelloux I, Boisset S Front Microbiol. 2024; 15:1507469.

PMID: 39669787 PMC: 11635305. DOI: 10.3389/fmicb.2024.1507469.


A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model.

Whelan A, Flick-Smith H, Walker N, Abraham A, Levitz S, Ostroff G PLoS One. 2024; 19(5):e0294998.

PMID: 38713688 PMC: 11075878. DOI: 10.1371/journal.pone.0294998.


Tularemia treatment: experimental and clinical data.

Maurin M, Ponderand L, Hennebique A, Pelloux I, Boisset S, Caspar Y Front Microbiol. 2024; 14:1348323.

PMID: 38298538 PMC: 10827922. DOI: 10.3389/fmicb.2023.1348323.


Pathogenicity and virulence of .

Degabriel M, Valeva S, Boisset S, Henry T Virulence. 2023; 14(1):2274638.

PMID: 37941380 PMC: 10653695. DOI: 10.1080/21505594.2023.2274638.


Contribution of Lipid Mediators in Divergent Outcomes following Acute Bacterial and Viral Lung Infections in the Obese Host.

Schwarz B, Roberts L, Bohrnsen E, Jessop F, Wehrly T, Shaia C J Immunol. 2022; 209(7):1323-1334.

PMID: 36002235 PMC: 9529825. DOI: 10.4049/jimmunol.2200162.


References
1.
Parsa K, Ganesan L, Rajaram M, Gavrilin M, Balagopal A, Mohapatra N . Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP. PLoS Pathog. 2006; 2(7):e71. PMC: 1513262. DOI: 10.1371/journal.ppat.0020071. View

2.
Burke D . Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis. 1977; 135(1):55-60. DOI: 10.1093/infdis/135.1.55. View

3.
Cole L, Santiago A, Barry E, Kang T, Shirey K, Roberts Z . Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways. J Immunol. 2008; 180(10):6885-91. PMC: 2637793. DOI: 10.4049/jimmunol.180.10.6885. View

4.
Elkins K, Cooper A, Colombini S, Cowley S, Kieffer T . In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. Infect Immun. 2002; 70(4):1936-48. PMC: 127864. DOI: 10.1128/IAI.70.4.1936-1948.2002. View

5.
EIGELSBACH H, DOWNS C . Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J Immunol. 1961; 87:415-25. View